![Ed Esplin: Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world](https://oncodaily.com/pub/uploads/2024/06/screen-17-1280x720.jpg)
Jun 15, 2024, 06:22
Ed Esplin: Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world
Ed Esplin, Clinical Geneticist at Invitae, shared a post on LinkedIn:
“1/3 of cancer patients with genetic testing in an Asian tertiary centre carried a germline PGV.
~75% of advanced cancer patients with actionable PGVs received corresponding targeted therapy.”
Read further in ESMO.
Read further in ASCO.
Source: Ed Esplin/LinkedIn